Advertisement admin, Author at Pharmaceutical Business review - Page 391 of 458
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by Lavillcok Lavillcok

La Jolla Pharma issued notice of allowance for patent

Specifically, the patent, which expires in 2025 without taking into account patent term extension, provides proprietary protection for methods of treating chronic inflammation by administration of modified pectin

MHI announces launch of ARTERIA program

The discoveries and innovations that will stem from this unique program will substantially benefit patients over the medium and long term by transforming medical practices in the treatment